drugset / Trial / NCT01893203

Daylight-PDT for AKs: Comparing Two Photosensitizers (BF-200 ALA and MAL)

NCT01893203

RandomizedSingle-groupDouble-blindTreatment

Summary

The aim of the study is to compare the efficacy of two photosensitizers, methyl-aminolaevulinate (MAL) and 5-aminolaevulinic nanoemulsion (BF-200 ALA) in the treatment of facial actinic keratosis. We use randomized, double-blinded prospective study design. The efficacy will be assessed clinically, histopathologically and immunohistochemically.

Timeline

Start
2013-08
Primary completion
2014-12
Completion
2014-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Aminolevulinic Acid Diagnostic / imaging agent 2 g Topical
Subject methyl aminolevulinate Small molecule 2 g Topical

Indications